| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/14/2009 | US20090123936 Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 05/14/2009 | US20090123926 characterized by substantial impairments of the genome, either in its structure, deletion or translocation and methods which allow genes to be located and mapped rapidly |
| 05/14/2009 | US20090123911 Isolated staphylococcus dnax subunit and use thereof |
| 05/14/2009 | US20090123626 Reducing the levels of asparagine in cells of the plant; potato chips, french fries, roasted coffee, wheat bread |
| 05/14/2009 | US20090123599 Cysteine Synthase Gene and Use Thereof |
| 05/14/2009 | US20090123572 Method and Pharmaceutical Composition for Treating Psoriasis, Squamous Cell Carcinoma and/or Parakeratosis by Inhibiting Expression of Squamous Cell Carcinoma-Related Antigen |
| 05/14/2009 | US20090123565 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 05/14/2009 | US20090123533 Compositions and methods for cancer diagnosis and therapy |
| 05/14/2009 | US20090123532 Oligonucleic acid-bearing composite and pharmaceutical composition containing the composite |
| 05/14/2009 | US20090123494 Momlv-based pseudovirion packaging cell line |
| 05/14/2009 | US20090123490 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 05/14/2009 | US20090123489 Novel immunotherapy against neuronal and brain tumors |
| 05/14/2009 | US20090123478 Human antibody molecules for IL-13 |
| 05/14/2009 | US20090123477 Antibodies |
| 05/14/2009 | US20090123476 Targeted binding agents directed to upar and uses thereof |
| 05/14/2009 | US20090123475 for isolation of DNA encoding anti-Rh(D) antibodies; isolation of DNA encoding antibodies directed against any red blood cells antigen or other cell antigen; for typing platelets by generating phage antibodies specific for a number of clinically important platelet antigens |
| 05/14/2009 | US20090123472 Detection of mutations in a gene associated with resistance to viral infection, oas1 |
| 05/14/2009 | US20090123466 Anti-cd40 monoclonal antibody |
| 05/14/2009 | US20090123463 Methods and compositions for inducing apoptosis |
| 05/14/2009 | US20090123461 Human podocalyxin alternative-spliced forms and uses thereof |
| 05/14/2009 | US20090123459 Compositions and method for the diagnosis, prevention and treatment of alzheimer's disease |
| 05/14/2009 | US20090123452 Protease screening methods and proteases identified thereby |
| 05/14/2009 | US20090123450 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation |
| 05/14/2009 | US20090123448 Nucleic acid molecules coding for a dextransaccharase catalysing the synthesis of dextran with alpha 1,2 osidic sidechains |
| 05/14/2009 | US20090123441 Engineered Dendritic Cells and Uses for the Treatment of Cancer |
| 05/14/2009 | US20090123440 using gutless adenovirus vector; gene therapy; gutless means incapable of expressing any adenovirus antigens; atherosclerosis |
| 05/14/2009 | US20090123438 Multivalent Vaccines Comprising Recombinant Viral Vectors |
| 05/14/2009 | US20090123428 Pathotropic targeted gene delivery system for cancer and other disorders |
| 05/14/2009 | US20090123426 Compositions for Bacterial Mediated Gene Silencing and Methods of Using the Same |
| 05/14/2009 | US20090123382 Light emitting microorganisms and cells for diagnosis and therapy of tumors |
| 05/14/2009 | US20090123370 Alphavbeta6 peptide ligands and their uses |
| 05/14/2009 | US20090120555 Novel amylolytic enzyme extracted from Bacillus sp. A 7-7 (DSM 12368) and washing and cleaning agents containing this novel amylolytic enzyme |
| 05/14/2009 | DE60226243T2 Peptid-bildendes Enzymgen, Pepid-bildendes Enzym und Dipeptidherstellungsverfahren Peptide-forming enzyme gene PEPID-forming enzyme and Dipeptidherstellungsverfahren |
| 05/14/2009 | CA2743032A1 Human monoclonal antibodies directed to sialyl lewis c, sialyl tn and n-glycolylneuraminic acid epitopes and a method of analysis of stem cells comprising said epitopes |
| 05/14/2009 | CA2723165A1 Sulfatase enzymes |
| 05/14/2009 | CA2706700A1 Compositions and methods for generating antibodies |
| 05/14/2009 | CA2705316A1 Modulation of factor 7 expression |
| 05/14/2009 | CA2705269A1 Jak2 mutations |
| 05/14/2009 | CA2705261A1 Methods and compositions for improved cattle longevity and milk production |
| 05/14/2009 | CA2705252A1 Methods and compositions for improved fertilization and embryonic survival |
| 05/14/2009 | CA2705160A1 Fusion proteins of mannose binding lectins for treatment of disease |
| 05/14/2009 | CA2704858A1 Compositions for conferring tolerance to viral disease in social insects, and the use thereof |
| 05/14/2009 | CA2704791A1 Variants of bacillus sp. ts-23 alpha-amylase with altered properties |
| 05/14/2009 | CA2704745A1 Alpha-amylase variants with altered properties |
| 05/14/2009 | CA2704644A1 Variants of bacillus licheniformis alpha-amylase with increased thermostability and/or decreased calcium dependence |
| 05/14/2009 | CA2704560A1 Use of oligonucleotides with modified bases in hybridization of nucleic acids |
| 05/14/2009 | CA2704556A1 West nile virus vaccine, and method for production thereof |
| 05/14/2009 | CA2704555A1 Alpha-amylase variants with altered properties |
| 05/14/2009 | CA2704549A1 Use of oligonucleotides with modified bases as antiviral agents |
| 05/14/2009 | CA2704494A1 Directed evolution using proteins comprising unnatural amino acids |
| 05/14/2009 | CA2704361A1 Mitochondrial dna deletion between about residues 12317-16254 for use in the detection of cancer |
| 05/14/2009 | CA2704236A1 Nucleic acid complex and nucleic acid delivery composition |
| 05/14/2009 | CA2704208A1 Association of single nucleotide polymorphisms in the cbfa2t1 and decr1 genes with performance and carcass merit of beef cattle |
| 05/14/2009 | CA2704016A1 Methods for increasing starch content in plants |
| 05/14/2009 | CA2703983A1 Catenate for immunostimulation |
| 05/14/2009 | CA2703884A1 Method and kit for preparation of sample for use in nucleic acid amplification |
| 05/14/2009 | CA2703395A1 Mycobacterium antigens |
| 05/14/2009 | CA2703243A1 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding lnt2 polypeptides and homologs thereof |
| 05/14/2009 | CA2700197A1 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 05/13/2009 | EP2058407A2 Invasive cleavage of nucleic acids |
| 05/13/2009 | EP2058405A1 Device and method for high-throughput quantification of mRNA from whole blood |
| 05/13/2009 | EP2058401A1 Widespread gene delivery to motor neurons using peripheral injection of AAV vectors |
| 05/13/2009 | EP2058400A1 Protein/(poly)peptide libraries |
| 05/13/2009 | EP2058399A1 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 05/13/2009 | EP2058398A1 Production of recombinant human hemoglobin using pichia yeast |
| 05/13/2009 | EP2058397A1 Multimere assembly for immunostimulation |
| 05/13/2009 | EP2058396A1 Nucleic acid amplification method |
| 05/13/2009 | EP2058395A1 Kif-derived peptide capable of binding to hla-a24 molecule |
| 05/13/2009 | EP2058394A1 Method for designing mutated enzyme, method for preparing the same and mutated enzyme |
| 05/13/2009 | EP2058393A1 Compositions and methods for preventing and treating immune-mediated inflammatory disorders |
| 05/13/2009 | EP2058392A1 Dna fragment used in the form attached to 5'-terminus of primer for use in amplification reaction of nucleic acid, and use thereof |
| 05/13/2009 | EP2058391A1 Method for highly amplifying target gene in mammalian cell and vector therefor |
| 05/13/2009 | EP2058390A1 Method for producing scyllo-inositol |
| 05/13/2009 | EP2058334A2 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 05/13/2009 | EP2058333A2 Anti-CCR2 antibodies and methods of use therefor |
| 05/13/2009 | EP2058329A1 Improved secretion of neublastin |
| 05/13/2009 | EP2058327A2 Genes encoding insect odorant receptors and uses thereof |
| 05/13/2009 | EP2058325A2 A method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library. application to the detection of mycobacteria |
| 05/13/2009 | EP2058006A1 Anti-CCR5 antibody |
| 05/13/2009 | EP2057284A1 Compositions and methods for the modulation of jnk proteins |
| 05/13/2009 | EP2057274A2 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 05/13/2009 | EP2057273A2 Use of subtilisin (rnr9) polynucleotides for achieving a pathogen resistance in plants |
| 05/13/2009 | EP2057272A2 Methods for producing transgenic plants |
| 05/13/2009 | EP2057271A2 Flavin monooxygenases and transcription factors involved in glucosinolate biosynthesis |
| 05/13/2009 | EP2057270A1 In-plant production of dimeric and/or oligomeric (comprising three or more units) forms of human apo a-1 protein muteins |
| 05/13/2009 | EP2057269A1 Family 6 cellulases with increased thermostability, thermophilicity, and alkalophilicity |
| 05/13/2009 | EP2057268A1 A dna vaccine for curing chronic hepatitis b and a method of preparing same |
| 05/13/2009 | EP2057267A2 Method for dissolving charged nucleic acid in an organic liquid |
| 05/13/2009 | EP2057266A1 Genetic remodeling in bifidobacterium |
| 05/13/2009 | EP2057265A2 Compositions for reducing cell adhesion to bubbles |
| 05/13/2009 | EP2057195A2 Pharmaceutical composition for suppression of apoptosis and method for delivering the same |
| 05/13/2009 | EP2057188A2 Dpp-iv resistant gip hybrid polypeptides with selectable properties |
| 05/13/2009 | EP2057180A1 Oligonucleotides for discriminating related nucleic acid sequences |
| 05/13/2009 | EP2057179A1 Compositions and methods for treating myelosuppression |
| 05/13/2009 | EP2057178A2 Phytases, nucleic acids encoding them and methods for making and using them |
| 05/13/2009 | EP2056883A2 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes |
| 05/13/2009 | EP2056880A1 Nucleic acid modulation of toll-like receptor-mediated immune stimulation |
| 05/13/2009 | EP2056872A2 Influenza hemagglutinin and neuraminidase variants |
| 05/13/2009 | EP2056852A2 Bmp-7 variant compositions, methods and uses |
| 05/13/2009 | EP2056840A2 Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna |